We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tiziana Life Sciences Plc | LSE:TILS | London | Ordinary Share | GB00BKWNZY55 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.50 | 45.00 | 60.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
20/9/2022 15:24 | That's very true | michelle74 | |
20/9/2022 15:20 | No, but it shows they are prepared to risk their capital in the same investment as ourselves. | david gruen | |
20/9/2022 15:15 | These directors are always buying shares, but that doesn't mean they are good stock pickers. | apollocreed1 | |
20/9/2022 14:17 | Sounds like it. | david gruen | |
20/9/2022 14:01 | Good news at last | michelle74 | |
20/9/2022 13:12 | NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. TLSA -0.90% + Free Alerts ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 29,318 common shares priced between $0.78 and $0.81 per share. The acquisition takes Mr Cerrone's interests from 37.70% to 37.72%. | david gruen | |
20/9/2022 12:01 | Tiziana Life Sciences Announces Continued Clinical Improvements in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) After Six Months of Dosing with Intranasal Foralumab | jpuff | |
09/9/2022 17:00 | Chief medical officer buys more shares you have to have hope | michelle74 | |
09/9/2022 15:24 | What makes you think that? | david gruen | |
09/9/2022 15:22 | Good news coming soon I think | michelle74 | |
02/9/2022 12:11 | lots and still worth diddly! | nerdofsteel | |
23/8/2022 11:38 | depends, how many of these FREE shares you have! | abbynat | |
22/8/2022 17:06 | sure, worth diddly squat tho.... | nerdofsteel | |
20/8/2022 08:36 | Anyone able to trade Accustem shares? | pennstreet | |
02/8/2022 17:03 | there's a good chance i might forget to tune in! | abbynat | |
01/8/2022 17:58 | Tiziana Life Sciences Announces Presentation at Alzheimer's Association International Conference® 2022 (AAIC®) Evaluating Intranasal anti-CD3 for the Potential Treatment of Alzheimer's Disease | jpuff | |
22/7/2022 11:04 | Yes I think we all need a bit of much here | michelle74 | |
21/7/2022 18:00 | A bit of a bounce today perhaps on the back of Tesla better than expected profits lol | jpuff | |
18/7/2022 11:06 | another CMO, what happened to the last one? | nerdofsteel | |
15/7/2022 22:24 | Dr KS has resigned as ceo. Not necessarily a bad thing imho | jpuff | |
12/7/2022 17:27 | I do miss those cosy fireside chats....hats off to these guys! What a sting...... | fandagle | |
06/7/2022 16:35 | Dr KS resigned from the board of Accustem. I think he remains on the Tiziana Life Sciences board | miidas | |
06/7/2022 14:58 | That'll be dr Kunwsr Shailubhai M. B. A. Others on the board, as follows. . . . Ooh. Look who's there?. Tiziana Life Sciences Ltd executives and other stock owners filed with the SEC include:Gabriele Marco Antonio Cerrone M.B.A., MBAFounder & Exec. ChairmanDr. Kunwar Shailubhai M.B.A., Ph.D.CEO, Chief Scientific Officer & Exec. DirectorDr. Kunwar ShailubhaiCEO, Chief Scientific Officer & Exec. DirectorGabriele Cer | lean5gb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions